121 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

7561

Bioray Biotech
NT$23.90-5.0%-28.0%NT$719.0mn/aPS3.7xn/a0%

6976

Acepodia
NT$28.853.0%n/aNT$16.4bn/aPS988.3xn/an/a

4157

TaiGen Biopharmaceuticals Holdings
NT$15.35-1.0%-1.9%NT$11.0bn/aPE80.6xn/an/a

7427

Great Novel Therapeutics Biotech & Medicals
NT$55.60-11.3%-35.9%NT$2.1bn/aPS441.2xn/an/a

3164

GenMont Biotech Incorporation
NT$23.305.2%-7.4%NT$2.0bn/aPE61.1xn/a3.0%

6562

UBI Pharma
NT$14.151.4%-64.2%NT$1.7bn/aPE2082.7xn/a0%

6696

Lin BioScience
NT$94.7029.4%-45.6%NT$7.4bn/aPB3.5xn/an/a

4119

SCI Pharmtech
NT$89.001.4%-20.2%NT$10.6bn/aPE36.1xn/a1.4%

6586

CHO Pharma
NT$55.10-0.5%-45.2%NT$11.8bn/aPB4xn/an/a

4726

Mycenax Biotech
NT$43.45-6.4%11.0%NT$8.9bn/aPS13.7xn/an/a

4131

NeoCore Technology
NT$31.200.6%10.2%NT$1.2bn/aPS19xn/an/a

4120

Orient EuroPharma
NT$42.002.3%13.5%NT$3.6bn/aPE25.3xn/a2.4%

3176

Medigen Biotechnology
NT$38.700.3%12.0%NT$5.4bn/aPS4.7xn/an/a

6549

TaiwanJ Pharmaceuticals
NT$13.209.5%-55.9%NT$991.6mn/aPS43.6xn/an/a

6949

PELL Bio-Med Technology
NT$166.0018.6%n/aNT$9.0bn/aPS496.6xn/an/a

6634

Sinew Pharma
NT$57.50-0.7%-32.0%NT$4.1bn/aPB3.1xn/an/a

6919

Caliway Biopharmaceuticals
NT$384.002.0%178.8%NT$53.5bn/aPS1375.1xn/an/a

6580

TaiRx
NT$38.05-2.9%12.6%NT$4.2bn/aPS825.1xn/an/a

6814

Lukas Biomedical
NT$29.800.8%-21.0%NT$1.1bn/aPS4.7xn/an/a

1760

Panion & Bf Biotech
NT$96.10-2.4%-41.0%NT$8.2bn/aPE106.7xn/a1.6%

6550

Polaris Group
NT$68.101.0%-29.2%NT$50.6bn/aPS14457.4xn/an/a

6875

Pharmosa Biopharm
NT$73.507.5%-8.9%NT$8.6bn/aPE1018.7xn/an/a

6677

Anxo Pharmaceutical
NT$45.251.3%-8.1%NT$2.5bn/aPE75.7xn/a0%

6794

UnicoCell Biomed
NT$86.402.9%13.1%NT$4.8bn/aPS195.7xn/an/a
Page 3 of 6
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.